Abcam, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation d...
TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small ...
Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combinat...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...
United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brai...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...
Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development....
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has ...
A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota tr...
A clinical stage pharma company, UroGen Pharma developing treatments to address unmet needs in the field of urology has ...
CellMax Life, a US based diagnostics company with a proprietary technology to detect precancer and cancer cells in blood...
Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...
Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and ...
Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...
Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...
Apellis Pharmaceuticals Inc. has provided an update on the status of its Phase 3 program for APL-2 in patients with...
Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...
Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that t...
